BG Medicine, Inc. (BGMD) Reports In-Line Q2 Loss
Tweet
Share
E-mailGet Alerts BGMD Hot Sheet
Join SI Premium – FREE
BG Medicine, Inc. (NASDAQ: BGMD) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $1.4 million.
For earnings history and earnings-related data on BG Medicine, Inc. (BGMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- Netlist (NLST) Misses Q1 EPS by 1c
- Ladder Capital (LADR) Tops Q1 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
